Marshall Wace’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-59,515
| Closed | -$158K | – | 2825 |
|
|
2024
Q4 | $158K | Buy |
+59,515
| New | +$158K | ﹤0.01% | 2227 |
|
|
2024
Q1 | – | Sell |
-10,085
| Closed | -$20K | – | 2408 |
|
|
2023
Q4 | $20K | Sell |
10,085
-47,632
| -83% | -$94.3K | ﹤0.01% | 1775 |
|
|
2023
Q3 | $75K | Sell |
57,717
-251,742
| -81% | -$327K | ﹤0.01% | 1740 |
|
|
2023
Q2 | $501K | Sell |
309,459
-317,467
| -51% | -$514K | ﹤0.01% | 1587 |
|
|
2023
Q1 | $1.34M | Buy |
626,926
+206,311
| +49% | +$439K | ﹤0.01% | 1313 |
|
|
2022
Q4 | $1.56M | Buy |
420,615
+347,185
| +473% | +$1.28M | ﹤0.01% | 1442 |
|
|
2022
Q3 | $55K | Sell |
73,430
-97,742
| -57% | -$73.2K | ﹤0.01% | 2459 |
|
|
2022
Q2 | $133K | Buy |
+171,172
| New | +$133K | ﹤0.01% | 2523 |
|
|
2021
Q2 | – | Sell |
-317,705
| Closed | -$2.1M | – | 2452 |
|
|
2021
Q1 | $2.1M | Buy |
+317,705
| New | +$2.1M | 0.01% | 1129 |
|
|
2015
Q4 | – | Sell |
-64,886
| Closed | -$945K | – | 1092 |
|
|
2015
Q3 | $945K | Hold |
64,886
| – | – | 0.01% | 631 |
|
|
2015
Q2 | $1.08M | Hold |
64,886
| – | – | 0.01% | 591 |
|
|
2015
Q1 | $1.42M | Buy |
64,886
+6,469
| +11% | +$142K | 0.02% | 522 |
|
|
2014
Q4 | $1.27M | Sell |
58,417
-55,259
| -49% | -$1.2M | 0.02% | 538 |
|
|
2014
Q3 | $1.95M | Buy |
+113,676
| New | +$1.95M | 0.03% | 447 |
|